Evaluation of serum cathepsin D concentrations in coronary artery disease

Indian Heart Journal
Amir Hooshang MohammadpourAmirhossein Sahebkar

Abstract

Coronary artery disease (CAD) cannot be sufficiently explained by the presence of traditional risk factors. Cathepsin D has been proposed to serve as a surrogate marker of atherosclerosis but its alterations in CAD patients have not been studied. To evaluate serum cathepsin D concentrations in relation to the presence and severity of CAD. A total of 104 subjects were recruited; 71 patients with suspected CAD and 33 healthy subjects. Thirty-four patients had >50% coronary stenosis of at least one artery (CAD+); the remaining 37 patients had <50% stenosis (CAD-) based on angiography. CAD+ patients were sub-divided into three sub-groups with single (SVD; n=15), double (2VD; n=9), and triple vessel (3VD; n=10) disease. Serum soluble cathepsin D concentrations were determined using an enzyme-linked immunosorbent assay (ELISA). Serum cathepsin D concentrations were significantly higher in the CAD+ compared with healthy control (p=0.016) but not CAD- group (p=0.098). Within the CAD+ group, patients with 3VD had significantly higher serum cathepsin D concentrations compared with the SVD group (p=0.025), and also compared with the CAD- (p=0.011) and SVD (p=0.001) groups. No significant associations were found between serum cathepsin D c...Continue Reading

Citations

Nov 24, 2020·BMC Complementary Medicine and Therapies·Ramakrishnan GanapathyM Walid Qoronfleh
Sep 13, 2020·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·Yu DingYanlin Zhang
Mar 20, 2020·Current Vascular Pharmacology·Dimitrios PatouliasCharles Faselis

❮ Previous
Next ❯

Methods Mentioned

BETA
hormone replacement therapy
coronary artery bypass
enzyme-linked immunosorbent assay

Software Mentioned

SPSS

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

© 2022 Meta ULC. All rights reserved